Cyclophosphamide/antithymocyte globulin conditioning of patients with severe aplastic anemia for marrow transplantation from HLA-matched siblings: Preliminary results

[1]  H. Deeg,et al.  Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. , 1994, Blood.

[2]  H. Deeg,et al.  Cyclophosphamide plus ATG conditioning is insufficient for sustained hematopoietic reconstitution in patients with severe aplastic anemia transplanted with marrow from HLA-A, B, DRB matched unrelated donors. , 1994, Blood.

[3]  H. Deeg,et al.  Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. , 1992, Blood.

[4]  A. Rimm,et al.  Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome. , 1992, Blood.

[5]  J. Cosset,et al.  Bone marrow transplantation in 107 patients with severe aplastic anemia using cyclophosphamide and thoraco-abdominal irradiation for conditioning: long-term follow-up. , 1991, Blood.

[6]  J. Cosset,et al.  Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia. , 1991, Blood.

[7]  J. Sanders.  The impact of marrow transplant preparative regimens on subsequent growth and development. The Seattle Marrow Transplant Team. , 1991, Seminars in hematology.

[8]  P. Meusers,et al.  Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group. , 1991, The New England journal of medicine.

[9]  E. Gluckman,et al.  Treatment with marrow transplantation or immunosuppression of childhood acquired severe aplastic anemia: a report from the EBMT SAA Working Party. , 1990, Bone marrow transplantation.

[10]  S. Jagannath,et al.  Methylprednisolone, cyclosporine and methotrexate for prophylaxis of acute graft-versus-host disease. , 1990, Bone marrow transplantation.

[11]  H. Deeg,et al.  Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. , 1989, The New England journal of medicine.

[12]  H. Deeg,et al.  Graft‐versus‐host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long‐term follow‐up of a controlled trial , 1989, British journal of haematology.

[13]  Rimm,et al.  Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results. , 1989, Blood.

[14]  D. Swirsky,et al.  Bone marrow transplantation for severe aplastic anaemia using cyclosporin: long-term follow-up. , 1989, Bone marrow transplantation.

[15]  E. Gluckman,et al.  Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT * SAA Working Party , 1988, British journal of haematology.

[16]  A. Jeffreys,et al.  Use of a hypervariable minisatellite DNA probe (33.15) for evaluating engraftment two or more years after bone marrow transplantation for aplastic anaemia , 1988, British journal of haematology.

[17]  J. Kersey,et al.  Therapy of severe aplastic anemia in young adults and children with allogeneic bone marrow transplantation , 1987 .

[18]  H. Kronenberg,et al.  Autoimmune hyperthyroidism associated with chronic graft-versus-host disease. , 1987, Transplantation.

[19]  K. Sullivan,et al.  Second marrow transplants in patients with aplastic anemia rejecting the first graft: use of a conditioning regimen including cyclophosphamide and antithymocyte globulin. , 1987, Blood.

[20]  P. Wernet,et al.  [Bone marrow transplantation in severe aplastic anemia]. , 2008, Deutsche medizinische Wochenschrift.

[21]  H. Deeg,et al.  Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease. , 1986, Blood.

[22]  H. Deeg,et al.  Marrow transplantation for severe aplastic anemia. Long-term outcome in fifty "untransfused" patients. , 1986, Annals of internal medicine.

[23]  R. Storb,et al.  Mixed Hematologic Chimerism After Allogeneic Marrow Transplantation for Severe Aplastic Anemia Is Associated With a Higher Risk of Graft Rejection and a Lessened Incidence of Acute Graft-Versus-Host Disease , 1986 .

[24]  E. Guinan,et al.  Efficacy of a cyclophosphamide-procarbazine-antithymocyte serum regimen for prevention of graft rejection following bone marrow transplantation for transfused patients with aplastic anemia. , 1985, Transplantation.

[25]  R. Storb.  Bone Marrow Transplantation for Aplastic Anemia , 1993, Cell transplantation.

[26]  R. Gale,et al.  Improved survival following bone marrow transplantation for aplastic anaemia , 1983, British journal of haematology.

[27]  H. Deeg,et al.  Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings. , 1983, Annals of internal medicine.

[28]  Kristine,et al.  Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients. , 1982, Blood.

[29]  E. Gluckman,et al.  Bone Marrow Transplantation in Severe Aplastic Anaemia: a Survey of the European Group for Bone Marrow Transplantation (E.G.B.M.T.) * , 1981, British journal of haematology.

[30]  E. Gordon-Smith,et al.  Immunosuppression with Cyclosporin A in Allogeneic Bone Marrow Transplantation for Severe Aplastic Anaemia: Preliminary Studies , 1981, British journal of haematology.

[31]  W. Woods,et al.  Total lymphoid irradiation and cyclophosphamide as preparation for bone marrow transplantation in severe aplastic anemia , 1980 .

[32]  R. Storb,et al.  Marrow transplantation for treatment of aplastic anaemia. , 1978, Clinics in haematology.

[33]  R. Storb,et al.  Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection. , 1977, The New England journal of medicine.

[34]  S. Shapiro,et al.  Letter: ABO blood types in congenital heart-disease. , 1975, Lancet.

[35]  R. Storb,et al.  Effect of prior blood transfusions on marrow grafts: abrogation of sensitization by procarbazine and antithymocyte serum. , 1974, Journal of immunology.

[36]  P. Neiman,et al.  Allogeneic marrow grafting for treatment of aplastic anemia. , 1974, Blood.